Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ABCM Abcam
14.990
+0.360+2.46%
Post Mkt Price
14.9900.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30
Assets
Current assets
Cash, cash equivalents and short term investments
-50.16% 109.6M -55.12% 95.1M -49.23% 95.1M 3.78% 219.9M
-Cash and cash equivalents
-50.16% 109.6M -55.12% 95.1M -49.23% 95.1M 3.78% 219.9M
-Accounts receivable
32.76% 61.6M -29.81% 33.2M -25.23% 33.2M -1.9% 46.4M
-Taxes receivable
52.17% 10.5M 176.32% 10.5M 64.06% 10.5M 50% 6.9M
-Other receivables
-- -- -- 8.9M -- 8.9M -- --
Inventory
25.27% 57.5M 35.66% 58.2M 43% 58.2M 5.76% 45.9M
Prepaid assets
-- -- -- 5.1M -- 5.1M -- --
Total current assets
-19.36% 257.8M -30.93% 211.5M -24.14% 211.5M 3.97% 319.7M
Non current assets
Net PPE
3.56% 165.7M 2.8% 161.7M -1.82% 161.7M 1.59% 160M
-Gross PPE
3.56% 165.7M 39.67% 219.7M 33.39% 219.7M 1.59% 160M
-Accumulated depreciation
-- -- -- -58M -- -58M -- --
Goodwill and other intangible assets
86.17% 625.9M 76.8% 599M 72.52% 599M -0.77% 336.2M
-Goodwill
119.83% 397.9M 97.94% 364.8M 89.21% 364.8M -1.79% 181M
-Other intangible assets
46.91% 228M 51.59% 234.2M 51.68% 234.2M 0.45% 155.2M
Total non current assets
59.85% 806.9M 50.38% 774.6M 45.44% 774.6M -2.04% 504.8M
Total assets
29.13% 1.06B 20.07% 986.1M 21.53% 986.1M 0.21% 824.5M
Liabilities
Current liabilities
Payables
11.75% 65.6M -46.65% 23.9M -46.53% 23.9M 22.55% 58.7M
-accounts payable
-0.7% 56.7M -70.28% 12.9M -70.55% 12.9M 22.8% 57.1M
-Total tax payable
456.25% 8.9M 428.57% 7.4M 722.22% 7.4M 14.29% 1.6M
-Other payable
-- -- -- 3.6M -- 3.6M -- --
Current debt and capital lease obligation
1546.91% 133.4M 1708.45% 128.4M 12.93% 128.4M 14.08% 8.1M
-Current debt
-- 119.4M -- 119.2M 12.03% 119.2M -- --
-Current capital lease obligation
72.84% 14M 29.58% 9.2M 26.03% 9.2M 14.08% 8.1M
Current liabilities
204.63% 203.8M 260% 187.2M 17.29% 187.2M 21.42% 66.9M
Non current liabilities
Long term debt and capital lease obligation
-5.76% 96.5M -7.83% 101.3M -15.93% 101.3M -6.82% 102.4M
-Long term capital lease obligation
-5.76% 96.5M -7.83% 101.3M -15.93% 101.3M -6.82% 102.4M
Derivative product liabilities
-- -- -- 0 -- -- -- --
Total non current liabilities
8.46% 133.3M 3.48% 142.8M -4.29% 142.8M -10.94% 122.9M
Total liabilities
77.61% 337.1M 73.68% 330M 6.87% 330M -1.71% 189.8M
Shareholders'equity
Share capital
0% 500K 0% 500K 25% 500K 0% 500K
-common stock
0% 500K 0% 500K 25% 500K 0% 500K
Retained earnings
7.87% 304.4M 5.73% 289.6M 13.26% 289.6M 3.64% 282.2M
Paid-in capital
1.28% 268.9M 1.21% 268.3M 94.14% 268.3M 0.15% 265.5M
Less: Treasury stock
-13.04% 2M -8.33% 2.2M -12% 2.2M -4.17% 2.3M
Total stockholders'equity
14.64% 727.6M 3.93% 656.1M 30.54% 656.1M 0.79% 634.7M
Total equity
14.64% 727.6M 3.93% 656.1M 30.54% 656.1M 0.79% 634.7M
Currency Unit
GBPGBPGBPGBP
Accounting Standards
NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.
CEO: Mr. Alan Thomas Hirzel
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...